Preventing Asthma Exacerbations: Warning Signs, Triggers, and Long-Term Strategies

By Dr. Frank Hull, MD — Board-Certified Pulmonologist, Advanced Asthma Clinic, Plantation, FL | Updated June 2026

An asthma exacerbation — a flare-up, an attack, a bad episode — is not just an inconvenience. Each one carries real risk: oxygen desaturation, respiratory failure, mechanical ventilation, and in the most severe cases, death. And each exacerbation causes measurable airway remodeling: structural changes to the bronchial wall that can permanently reduce lung function if the cycle of inflammation and injury repeats over years.

The core message of modern asthma care is this: frequent exacerbations are a sign of undertreated disease, not an inevitable feature of having asthma. With the right diagnosis, the right controller therapy — and for eligible patients, the right biologic — the vast majority of asthma attacks are preventable.

At Advanced Asthma Clinic in Plantation, FL, Dr. Frank Hull has helped hundreds of patients across Broward County go from multiple hospitalizations per year to zero exacerbations. This article explains how.

What Is an Asthma Exacerbation?

An asthma exacerbation is a progressive, acute worsening of airflow obstruction and symptoms that goes beyond day-to-day variability. Clinically, exacerbations are categorized by severity:

GINA guidelines classify asthma as uncontrolled if any of the following occurred in the prior 12 months: hospitalization for asthma, emergency department visit, two or more exacerbations requiring oral corticosteroids, or any intubation for asthma. Uncontrolled asthma is an indication to step up treatment — and a prompt to evaluate for biologic therapy.

Early Warning Signs: Your Personal Asthma Prodrome

Most asthma exacerbations do not begin abruptly. There is typically a prodromal phase — hours to days of worsening that, if recognized and acted on, provides a window to intervene before a full-blown attack develops.

Common Early Warning Signs

• Nighttime cough waking you from sleep, or increased cough on waking
• Needing your rescue (short-acting bronchodilator) inhaler more than twice per week
• Morning chest tightness or wheeze that takes longer than usual to clear
• Reduced exercise tolerance — activities you normally manage now causing breathlessness
• Peak flow readings consistently below 80% of personal best on two or more mornings in a row
• Increased mucus production or change in mucus color
• A general sense of tightness or discomfort that is new or different from your baseline

Many patients develop a personal prodrome that is highly consistent across their exacerbations. Identifying yours — whether it is a change in cough character, a particular tightness under the sternum, or a predictable pattern of peak flow decline — and documenting it in your written asthma action plan is one of the most powerful tools in exacerbation prevention.

Peak Flow Monitoring as an Early Warning System

A peak flow meter costs less than $30 and provides objective, reproducible data on airway function in real time. Patients who monitor peak flow twice daily (morning and evening) can detect a developing exacerbation days before it becomes clinically obvious — and act accordingly.

Identifying and Reducing Your Personal Triggers

Triggers are exposures that provoke airway inflammation or bronchospasm in a sensitized airway. They do not cause asthma — but they can tip a well-controlled airway into exacerbation, and a poorly controlled airway into crisis. Identifying your specific triggers is not guesswork; it requires systematic assessment.

Major Exacerbation Triggers

Reducing trigger exposure is most effective when targeted to your specific sensitivities, confirmed by allergy testing and pulmonary assessment. Blanket trigger avoidance recommendations that are not tailored to your profile waste effort and often miss the actual drivers of your flares.

The Foundation of Exacerbation Prevention: Controller Therapy

No amount of trigger avoidance or rescue inhaler use compensates for inadequate daily controller therapy. The inflammatory process driving asthma does not switch off between symptoms — it smolders continuously, priming the airways for the next exacerbation. Controller medications interrupt this process when taken consistently every day.

Adherence: The Biggest Missed Opportunity

Studies consistently show that 50-70% of asthma patients do not take their controller inhaler as prescribed. Before stepping up therapy or considering biologics, honest assessment of adherence is essential. Common reasons for non-adherence include:

• Feeling well and not perceiving the need for daily medication
• Fear of steroid side effects from inhaled corticosteroids (note: inhaled corticosteroids at standard doses have minimal systemic absorption)
• Inhaler technique errors rendering each dose ineffective
• Forgetting or inconvenient dosing schedule
• Cost barriers — addressed at our clinic through the Better Breathing Grant

Establishing a consistent once-daily dosing routine tied to another daily habit (morning teeth-brushing, for example) dramatically improves adherence. Inhaler technique review at every clinic visit is standard practice at Advanced Asthma Clinic.

Stepping Up Controller Therapy

GINA guidelines define a five-step treatment ladder. Patients who experience exacerbations despite adherence to their current step should be evaluated for stepping up:

• Step 1-2: Low-dose ICS (or as-needed ICS-formoterol); suitable for intermittent or mild persistent asthma
• Step 3: Low-dose ICS-LABA; appropriate for moderate persistent asthma
• Step 4: Medium-dose ICS-LABA; add-on LAMA; consider referral to specialist
• Step 5: High-dose ICS-LABA + LAMA; add-on biologic therapy; specialist-only

Patients still experiencing exacerbations at Step 4-5 despite good adherence are candidates for biologic therapy evaluation.

Biologic Therapy: Breaking the Exacerbation Cycle

For patients with severe, type 2 (T2-high) asthma, biologic therapies represent the most significant advance in exacerbation prevention in decades. These targeted agents directly suppress the inflammatory pathways that drive recurrent flares.

Exacerbation Reduction in Clinical Trials

Real-world outcomes often exceed trial data. At Advanced Asthma Clinic, patients who were previously admitted 2-4 times per year routinely achieve zero exacerbations within 12 months of starting the right biologic. Request an appointment to discuss your biomarker profile and biologic eligibility.

Oral Steroid Reduction: A Critical Exacerbation Prevention Goal

Patients on chronic oral corticosteroids are caught in a destructive paradox: the steroids suppress the acute inflammation, but their immunosuppressive effects increase susceptibility to the very respiratory infections that are the most common exacerbation trigger. Biologic therapy is the most effective proven strategy for reducing or eliminating oral steroid dependence in severe asthma.

Comorbidity Management: The Hidden Exacerbation Drivers

Treating asthma in isolation while ignoring comorbid conditions is one of the most common reasons for persistent exacerbations despite optimal inhaler therapy. Key comorbidities to evaluate and control include:

• Chronic rhinosinusitis / nasal polyps: Upper airway inflammation directly drives lower airway disease via the unified airway concept. Treatment with nasal corticosteroids, saline irrigation, and in some cases endoscopic sinus surgery can dramatically improve asthma control. Dupilumab is FDA-approved for both severe asthma and chronic rhinosinusitis with nasal polyps.
• GERD (gastroesophageal reflux disease): Micro-aspiration of gastric acid and vagally-mediated bronchoconstriction from reflux are significant and under-recognized asthma triggers. Up to 75% of severe asthma patients have GERD. Effective acid suppression can reduce exacerbation frequency in this subset.
• Obesity: Mechanical restriction of the chest wall, increased airway inflammation, and GERD all contribute to worsened asthma in obese patients. Weight reduction of 10-15% has been shown to improve FEV1, reduce rescue inhaler use, and decrease exacerbations independent of other therapy changes.
• Anxiety and depression: Both are highly prevalent in severe asthma and independently increase exacerbation risk via multiple pathways, including hyperventilation, poor medication adherence, and direct neurogenic effects on airway tone.
• Obstructive sleep apnea (OSA): Nocturnal hypoxia and inflammation from untreated OSA worsen asthma control, particularly nocturnal symptoms. CPAP therapy in patients with both conditions frequently improves asthma control scores.

Vaccination: A Proven Exacerbation Prevention Strategy

Respiratory viral infections are the leading precipitant of asthma exacerbations across all age groups. Vaccination is one of the most cost-effective, evidence-based tools for preventing virus-triggered flares:

• Annual influenza vaccine: Strongly recommended for all asthma patients. Influenza-triggered asthma exacerbations are common, severe, and often require hospitalization. Inactivated (injectable) vaccine is preferred in asthma patients; avoid live attenuated intranasal influenza vaccine (LAIV) in patients with active wheezing.
• COVID-19 vaccination: Up-to-date COVID-19 vaccination (including current-strain boosters) is recommended for all asthma patients. See our full guide to asthma and COVID-19.
• Pneumococcal vaccine: PCV20 or PPSV23 for asthma patients who smoke (any age), and for all patients aged 65 and older.
• RSV vaccine: Abrysvo or Arexvy for asthma patients aged 60 and older. RSV is an underappreciated cause of severe exacerbations in older adults.
• Pertussis (Tdap): Whooping cough can cause prolonged cough and exacerbate reactive airway disease. Ensure Tdap booster is current.

The Post-Exacerbation Visit: Closing the Loop

A scheduled follow-up visit within 1-4 weeks of any moderate or severe exacerbation is one of the most evidence-based, consistently neglected interventions in asthma care. This visit should accomplish:

1. Assess recovery: Confirm airflow has returned to baseline (spirometry) and symptom control is re-established.
2. Identify the precipitant: Was this triggered by infection, allergen exposure, medication non-adherence, a new environmental exposure, or apparent spontaneous worsening? Each answer has different prevention implications.
3. Review and update the action plan: Was the written action plan followed? Were there barriers? What is the new plan for the next prodromal episode?
4. Step up therapy: Any patient who required systemic steroids, an ED visit, or hospitalization almost certainly needs a treatment step-up. If already at Step 4-5, evaluate for biologic therapy.
5. Address adherence: Non-adherence is a leading modifiable cause of exacerbations. Identify barriers and problem-solve concretely.
6. Biomarker re-assessment: Blood eosinophil count and FeNO should be measured at the follow-up visit to guide decisions about biologic eligibility and endotype characterization.

At Advanced Asthma Clinic, post-exacerbation visits are prioritized for same-week scheduling. If you have recently had a severe flare, contact us at 954-522-7226 to arrange urgent follow-up.

A Personal Exacerbation Prevention Plan: The Five Pillars

Every asthma patient should be able to articulate their personal prevention strategy across five domains:

1. Daily controller therapy: What am I taking, when, and have I had my inhaler technique verified in the last 12 months?
2. Trigger identification and reduction: What are my confirmed personal triggers? What specific measures am I taking to reduce exposure?
3. Early warning recognition: What does my personal prodrome look like? What peak flow threshold triggers me to act?
4. Written action plan: Do I have an up-to-date written plan that specifies exactly what to do at each zone level, including when to call my doctor and when to go to the ED?
5. Regular specialist review: When is my next appointment with my pulmonologist? Is it before my next exacerbation season, not after?

Advanced Asthma Exacerbation Prevention in Plantation, FL

Dr. Frank Hull specializes in patients who have not achieved adequate control with standard therapy — those with recurrent hospitalizations, oral steroid dependence, or exacerbations that interfere with daily life. Our clinic serves patients throughout Broward County, including Plantation, Fort Lauderdale, Davie, Miramar, Hollywood, Pembroke Pines, Cooper City, and Weston.

Services directly relevant to exacerbation prevention include:

• Comprehensive pulmonary function testing: spirometry, diffusion capacity, FeNO, methacholine challenge
• Biomarker workup for biologic eligibility (blood eosinophils, IgE, periostin)
• Biologic therapy initiation and monitoring for all FDA-approved asthma biologics
• Oral steroid reduction and elimination programs
• Comprehensive written asthma action plans
• Allergy evaluation and immunotherapy referral for allergen-driven disease
• Access to clinical trial opportunities for investigational asthma therapies